Back to on-line brokerage



HEALTH-2007-1.3-4: Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics

HEALTH-2007-1.4-4: Development of emerging gene therapy tools and technologies for clinical application

HEALTH-2007-2.2.1-1: Stroke and mechanisms underlying ischemic brain damage

HEALTH-2007-2.4.1-7: Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy

ICT-2007.3.6: Micro/nanosystems

ICT-2007.8.1: FET proactive 1: Nano-scale ICT devices and systems

NMP-2007-1.1-1 Nano-scale mechanisms of bio/non-bio interactions

NMP-2007-1.1-2 Self-assembling and self-organisation

NMP-2007-1.1-3 Support to networking ICPC3 researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications

NMP-2007-1.1-4 Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory

NMP-2007-1.1-5 ERANET Plus in nanosciences (This topic is subject to a joint call for ERA-NETs across the Themes. For further information see Annex 4.)

NMP-2007-1.2-1 Pilot lines to study, develop and up-scale nanotechnology-based processes from laboratory

NMP-2007-1.2-2 Equipment and methods for nanotechnology

NMP-2007-1.2-3 Analysis of the ethical, regulatory, social and economic environment of nanomedicine

NMP-2007-1.2-4 Coordination in nanometrology

NMP-2007-1.2-5 Examining capacity building in nanobiotechnology

NMP-2007-1.3-1 Specific, easy-to-use portable devices for measurement and analysis

NMP-2007-1.3-2 Risk assessment of engineered nanoparticles on health and the environment

NMP-2007-1.3-3 Scientific review of the data and studies on the potential impact of engineered nano-particles on health, safety and the environment

NMP-2007-1.3-4 Creation of a critical and commented database on the health, safety and environmental impact of nanoparticles

NMP-2007-1.3-5 Coordination in studying the environmental, safety and health impact of engineered nanoparticles and nanotechnology based materials and products

NMP-2007-2.1-1 Nanostructured polymer-matrix composites

NMP-2007-2.1-2 Nanostructured coatings and thin films

NMP-2007-2.1-3 Characterisation of nanostructured materials

NMP-2007-2.2-1 Organic materials for electronics and photonics

NMP-2007-2.2-2 Nanostructured materials with tailored magnetic properties

NMP-2007-2.2-3 Advanced material architectures for energy conversion

NMP-2007-2.4-2 Nanostructured catalysts with tailor-made functional surfaces

NMP-2007-2.4-3 Renewable materials for functional packaging applications

NMP-2007-2.5-2 Modelling of microstructural evolution under work conditions and in materials processing

NMP-2007-3.5-1 Processes and equipment for high quality industrial production of 3-dimensional nanosurfaces

NMP-2007-4.0-1 Advanced wood-based composites and their production

NMP-2007-4.0-4 Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-vivo diagnosis and therapy (in coordination with topic HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3 in Theme 1 Health)